The SELECT trial included more than 17,000 overweight or obese patients with a baseline age of 45 years or older
As part of a comprehensive weight loss program, Semaglutide can help reduce cravings, improve portion control, and support meaningful weight loss while helping patients develop healthier habits for long-term success
It's important to follow recommended dosages
Software for non-parametric image registration of 2-photon imaging data
In a statement to Insider, Novo Nordisk, the company that makes Wegovy and Ozempic, said that Gila monsters and the discovery of exendin-4 "did not have anything to do with our decision to develop long-acting GLP-1 receptor agonists" for obesity, because "that was based on GLP-1 biology in humans." But the company also said that "the GLP-1-like effect of exendin-4" in Gila monsters was "an important contribution to the field," as it led to the development of the very first injectable drug of its kind
And that changes a lot of things